OpenAI announced the launch of Rosalind Biodefense on Friday. The company said the initiative is aimed at helping trusted developers build new biodefense and help scientists detect biological threats, and developing "pandemic preparedness capabilities". "We want to help the world get a head start on biodefense," CEO Sam Altman said, adding that the initiative will help combat future pandemics.